Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 71
- −2 vs. Q3 2022
- Portfolio value
- $1.86B
- +$80.1M (+4.5%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RXDXPrometheus Biosciences, Inc. | COM | 1,897,500 | $208.7M | 11.2% | +183,500+10.7% | Added | History |
| ONCBeOne Medicines Ltd. | ADR | 500,000 | $110.0M | 5.9% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $96.2M | 5.2% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 3,984,264 | $94.9M | 5.1% | 00.0% | Unchanged | History |
| MRTXMirati Therapeutics, Inc. | COM | 2,000,000 | $90.6M | 4.9% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,421,541 | $89.0M | 4.8% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,576,000 | $81.5M | 4.4% | +272,300+20.9% | Added | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 2,084,000 | $77.0M | 4.1% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 7,123,642 | $51.6M | 2.8% | +252,000+3.7% | Added | History |
| TYRATyra Biosciences, Inc. | COM | 6,448,359 | $49.0M | 2.6% | 00.0% | Unchanged | History |
| RETAReata Pharmaceuticals Inc | CL A | 1,230,004 | $46.7M | 2.5% | −8,996−0.7% | Reduced | History |
| AKROAkero Therapeutics, Inc. | COM | 831,495 | $45.6M | 2.5% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 2,154,058 | $42.1M | 2.3% | 00.0% | Unchanged | History |
| SAGESage Therapeutics, Inc. | COM | 1,094,000 | $41.7M | 2.2% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $40.3M | 2.2% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $40.0M | 2.2% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 1,210,192 | $36.0M | 1.9% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 2,169,132 | $32.4M | 1.7% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 400,000 | $30.9M | 1.7% | +400,000 | New | History |
| RCUSArcus Biosciences, Inc. | COM | 1,432,200 | $29.6M | 1.6% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 1,900,000 | $29.4M | 1.6% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $28.7M | 1.5% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 2,325,000 | $28.4M | 1.5% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 850,000 | $27.9M | 1.5% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 3,163,795 | $27.5M | 1.5% | 00.0% | Unchanged | History |
| Bellus Health Inc New07987C204 | COM NEW | 3,200,000 | $26.3M | 1.4% | 00.0% | Unchanged | – |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $25.6M | 1.4% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,121,327 | $24.9M | 1.3% | 00.0% | Unchanged | – |
| XENEXenon Pharmaceuticals Inc. | COM | 600,000 | $23.7M | 1.3% | 00.0% | Unchanged | History |
| GERNGeron Corp | COM | 8,100,000 | $19.6M | 1.1% | +8,100,000 | New | History |
| EXELExelixis, Inc. | COM | 1,150,000 | $18.4M | 1.0% | −100,000−8.0% | Reduced | History |
| PNTPOINT Biopharma Global Inc. | COM | 2,500,000 | $18.2M | 1.0% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 300,000 | $18.1M | 1.0% | 00.0% | Unchanged | History |
| ETNB89bio, Inc. | COM | 1,400,000 | $17.8M | 1.0% | 00.0% | Unchanged | History |
| ISEEIVERIC bio, Inc. | COM | 825,000 | $17.7M | 1.0% | +825,000 | New | History |
| Rain Oncology Inc.75082Q105 | COM | 2,147,212 | $17.2M | 0.9% | +972,212+82.7% | Added | – |
| VKTXViking Therapeutics, Inc. | COM | 1,500,000 | $14.1M | 0.8% | +1,500,000 | New | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,224,892 | $13.4M | 0.7% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 1,250,000 | $12.6M | 0.7% | +900,000+257.1% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 95,000 | $11.6M | 0.6% | +25,000+35.7% | Added | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,074,082 | $11.3M | 0.6% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,505,133 | $9.62M | 0.5% | −430,000−22.2% | Reduced | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,054,000 | $7.36M | 0.4% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 3,336,928 | $7.24M | 0.4% | −235,000−6.6% | Reduced | History |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $6.21M | 0.3% | 00.0% | Unchanged | – |
| COGTCogent Biosciences, Inc. | COM | 525,000 | $6.07M | 0.3% | +100,000+23.5% | Added | History |
| BCABBioAtla, Inc. | COM | 686,347 | $5.66M | 0.3% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 150,000 | $5.13M | 0.3% | +150,000 | New | History |
| CABACabaletta Bio, Inc. | COM | 540,000 | $5.00M | 0.3% | 00.0% | Unchanged | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 459,836 | $4.31M | 0.2% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 3,284,072 | $3.71M | 0.2% | 00.0% | Unchanged | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,014,858 | $3.63M | 0.2% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 510,000 | $3.11M | 0.2% | −1,012,559−66.5% | Reduced | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 698,861 | $2.77M | 0.1% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 500,000 | $2.51M | 0.1% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 250,000 | $2.50M | 0.1% | −150,000−37.5% | Reduced | History |
| EQRXEQRx, Inc. | COM | 1,000,000 | $2.46M | 0.1% | 00.0% | Unchanged | History |
| THRDThird Harmonic Bio, Inc. | COM | 570,417 | $2.45M | 0.1% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 1,450,000 | $2.22M | 0.1% | −684,598−32.1% | Reduced | History |
| THRXTheseus Pharmaceuticals, Inc. | COM | 415,000 | $2.07M | 0.1% | −477,057−53.5% | Reduced | History |
| VERUVeru Inc. | COM | 347,300 | $1.83M | 0.1% | −2,152,700−86.1% | Reduced | History |
| BCELAtreca, Inc. | CL A COM | 2,202,333 | $1.76M | 0.1% | 00.0% | Unchanged | History |
| MREOMereo BioPharma Group plc | SPON ADS | 2,250,000 | $1.69M | 0.1% | 00.0% | Unchanged | History |
| TCRTAlaunos Therapeutics, Inc. | COM | 1,500,000 | $973.6K | 0.1% | 00.0% | Unchanged | History |
| LITSLite Strategy, Inc. | COM NEW | 2,913,091 | $709.6K | <0.1% | 00.0% | Unchanged | History |
| TARAProtara Therapeutics, Inc. | COM STK | 209,227 | $560.7K | <0.1% | 00.0% | Unchanged | History |
| IRONDisc Medicine, Inc. | COM | 130,000 | $175.5K | <0.1% | 00.0% | UnchangedConverted for a 1-for-10 split | History |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 56,950 | $41.0K | <0.1% | 00.0% | Unchanged | – |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $38.5K | <0.1% | 00.0% | Unchanged | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 66,666 | $4.39K | <0.1% | 00.0% | Unchanged | – |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,251,137 | – | – | 00.0% | Unchanged | History |
Sold out since Q3 2022 (7)
Positions held at the end of Q3 2022 that are gone from this filing.
| Security | Class | Shares in Q3 2022 | Value in Q3 2022 | % of portfolio in Q3 2022 | History |
|---|---|---|---|---|---|
| SRPTSarepta Therapeutics, Inc. | COM | 200,000 | $22.1M | 1.2% | History |
| ACADAcadia Pharmaceuticals Inc | COM | 1,263,930 | $20.7M | 1.2% | History |
| BPMCBlueprint Medicines Corp | COM | 275,000 | $18.1M | 1.0% | History |
| ALTAltimmune, Inc. | COM NEW | 500,000 | $6.38M | 0.4% | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $5.01M | 0.3% | – |
| Omega Alpha SpacG6749V107 | CL A | 200,000 | $1.99M | 0.1% | – |
| CDAKCodiak BioSciences, Inc. | COM | 488,157 | $382.0K | <0.1% | History |